New drug AVM0703 tested for Life-Threatening lung failure
Disease control
Not yet recruiting
This early-stage study tests a single dose of a new drug called AVM0703 in 16 adults with severe breathing failure (ARDS) caused by COVID-19 or the flu. The main goal is to check if the drug is safe and how the body processes it. Participants are randomly assigned to receive the …
Phase: PHASE1 • Sponsor: AVM Biotechnology Inc • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC